Clinical Trial: Predicting histological grading of pancreatic ductal adenocarcinoma using portal venous phase contrast-enhanced CT radiomics: Multi-omics integration and multicenter external validation (China)

Posted On: 2026-11-06

China, Nov. 6 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Predicting histological grading of pancreatic ductal adenocarcinoma using portal venous phase contrast-enhanced CT radiomics: Multi-omics integration and multicenter external validation'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600136134

Registration Time: 2026/11/05

Type: Observational study

Primary Sponsor: Chongqing General Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=339188

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Predicting histological grading of pancreatic ductal adenocarcinoma using portal venous phase contrast-enhanced CT radiomics: Multi-omics integration and multicenter external validation (China)